TWO SIGMA INVESTMENTS, LP - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 62 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,360
-99.4%
19,200
-97.1%
0.00%
-100.0%
Q2 2022$564,000
-68.5%
662,593
+104.1%
0.00%
-60.0%
Q1 2022$1,789,000
-35.6%
324,661
+13.1%
0.01%
-16.7%
Q4 2021$2,778,000
-37.0%
286,967
+16.4%
0.01%
-40.0%
Q3 2021$4,409,000
+21.5%
246,566
+65.9%
0.01%
+25.0%
Q2 2021$3,629,000
+2196.8%
148,656
+616.2%
0.01%
Q4 2020$158,000
-33.1%
20,755
-55.9%
0.00%
-100.0%
Q3 2020$236,000
-43.4%
47,091
-32.5%
0.00%
-50.0%
Q2 2020$417,000
+4.5%
69,719
-22.3%
0.00%
-33.3%
Q1 2020$399,00089,7010.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders